Natalizumab

abx831019-5nmol

Natalizumab

631 €

E40YR1032

Natalizumab

Available in various conjugation types.

4590 €

HY-108831

Natalizumab

Natalizumab is a recombinant, humanized IgG4 monoclonal antibody, binds to α4β1-integrin and blocks its interaction with vascular cell adhesion molecule-1 (VCAM-1). Natalizumab can be used for the treatment of relapsing remitting multiple sclerosis and Crohn's disease. Natalizumab is also the first targeted therapy which blocks an essential mechanism for lymphocyte entry to the CNS and thus prevents acute demyelinating relapses[1].

733.84 €

PHY2002S

Natalisin Antibody

216.75 €

MBS7083129-INQUIRE

Recombinant Natalus major Cytochrome b (MT-CYB), partial

Ask for quotation

MBS1477610-002mgBaculovirus

Recombinant Natalus stramineus Sperm protamine P1 (PRM1)

1428.12 €